| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615899 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 22 Pages |
Abstract
This study suggests that the efficacy and safety of generic imatinib in this Middle Eastern population in routine clinical practice are comparable to patented imatinib, and to that of the global population.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Abdalla Awidi, Salah Abbasi, Kamal Alrabi, Khalid A. Kheirallah,